AIAsma Iqbal

Asma Iqbal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Asma Iqbal has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perioperative dexmedetomidine for the prevention of postoperative delirium in elderly patients undergoing orthopedic surgery: a systematic review and meta-analysis of randomized controlled trials

    by Syed Faqeer Hussain Bokhari, Affaf Mahmood, Saira Shamim, Khansa Mehmood, Rabia Amjad, Abdul Saboor Khan, Aiman Jeet Kaur, Ibrahim Salau, Fnu Maryam, Ahmad Hassan, et al.

    Background: Postoperative delirium (POD) is a frequent and morbid complication in elderly patients undergoing orthopedic surgery. Although dexmedetomidine has been studied for delirium prevention in mixed surgical populations, evidence specific to orthopedic procedures and perioperative administration strategies remains fragmented. Objective: To evaluate the efficacy and cardiovascular safety of perioperative dexmedetomidine for POD prevention in elderly patients undergoing orthopedic surgery and to examine its impact on recovery outcomes. Methods: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials (RCTs) comparing perioperative dexmedetomidine with placebo or standard care in adults undergoing orthopedic surgery was conducted. The primary outcome was POD incidence. Secondary outcomes included time-specific delirium, perioperative cardiovascular adverse events, length of hospital stay, in-hospital complications, and mortality. Results: Seven RCTs, including 2060 patients, were analyzed. Dexmedetomidine significantly reduced overall POD incidence [odds ratio (OR) = 0.42; 95% CI 0.32–0.54; I 2 = 0%; P < 0.00001]. Time-specific reductions were observed at 24 h (OR = 0.36; 95% CI 0.22–0.57; P < 0.0001) and 72 h (OR = 0.46; 95% CI 0.24–0.87; P = 0.02), but not at 48 h (OR = 0.38; 95% CI 0.12–1.15; P = 0.09). Intraoperative cardiovascular adverse events were increased overall (OR = 1.65; 95% CI 1.10–2.47; P = 0.02), while individual events were not significantly different. Postoperatively, hypertension was reduced (OR = 0.52; 95% CI 0.30–0.91; P = 0.02). Hospital stay was significantly shorter (mean difference = −1.31 days; 95% CI −1.93 to −0.69; P < 0.0001), with no significant differences in in-hospital complications (OR = 0.74; P = 0.06) or mortality (OR = 0.89; P = 0.83). Conclusion: Perioperative dexmedetomidine reduces POD and improves recovery in elderly orthopedic patients, with manageable cardiovascular effects under monitoring. Further large-scale trials are needed to determine optimal dosing, timing, and long-term neurocognitive outcomes.

  • Safety and efficacy of anti-CD20 monoclonal antibodies versus teriflunomide in relapsing multiple sclerosis: a systematic review and meta-analysis

    by Hafiz Muhammad Haris, Hafiz Asad Ullah, Gul Sher Ghouri, Ali Hassan, Waleed Maqsood, Zainab Zaffar, Iman Fatima, Fnu Laiba, Rishmail Tariq, Muhammad Waleed Khan, et al.

  • Open Access

    Safety and efficacy of pulsed field ablation versus cryoablation for atrial fibrillation: A comprehensive meta-analysis

    by Syed Faqeer Hussain Bokhari, Danyal Bakht, Maaz Amir, Ahmad Hassan, Ahmed Asif, Khawar Ali, Muhammad Khan Buhadur Ali, Hania Sana, Muhammad Ahmad Qureshi, Mohammad Maheer Mubashir, et al.

    Background: Atrial fibrillation (AF) remains the most common sustained cardiac arrhythmia. Pulsed field ablation (PFA) and cryoablation (CA) aim to isolate pulmonary veins and prevent AF recurrence. This meta-analysis aims to provide a comprehensive comparison of PFA and CA in treatment of AF in context of efficacy, procedural characteristics, and safety profiles. Methods: A comprehensive literature search of databases (PubMed, Cochrane Library, Science Direct and Google Scholar) was conducted from their inception to September 2024. Statistical analyses were conducted using Cochrane’s RevMan 5.4 software. Results: Twenty studies (n = 4638; PFA = 2172, CA = 3033) were included in this meta-analysis. Regarding efficacy outcomes, PFA significantly reduced AF recurrence (odds ratio [OR] = 0.68 [0.50–0.94], P = .02) and improved 1-year freedom from atrial arrhythmia (OR = 1.65 [1.18–2.31], P = .004) compared to CA. Procedurally, it demonstrated shorter procedure duration (mean difference [MD] = −11.07 [−14.57 to −7.56], P < .00001), lower contrast dye use (MD = −51.62 [−66.35 to −36.88], P < .00001), and smaller fluoroscopy dose (MD = −5.28 [−9.32 to −1.24], P = .01), though it required more applications (MD = 20.73 [4.98–36.48], P = .01), longer fluoroscopy time (MD = 1.55 [0.68–2.42], P = .0005), and higher post-pulmonary vein isolation high sensitivity cardiac troponin T levels (MD = 570.40 [410.94–729.86], P < .00001). Regarding safety, PFA was associated with a lower overall complication rate (OR = 0.46 [0.32–0.66], P < .0001) and reduced risk of persistent (OR = 0.13 [0.04–0.42], P = .0008) and transient (OR = 0.12 [0.05–0.30], P < .00001) phrenic nerve palsy, but a higher incidence of cardiac tamponade (OR = 2.86 [1.26–6.48], P = .01) and atrial tachycardia (OR = 2.62 [1.41–4.87], P = .002). It also showed superior postoperative heart rate improvement (MD = −8.76 [−15.12 to −2.40], P = .007). Conclusion: PFA offers superior efficacy and some procedural advantages over CA in AF treatment, though with increased risk of certain complications.


  • A comprehensive review of infection risks and management in hemodialysis access sites

    by Syed Faqeer Hussain Bokhari, Asma Iqbal, Shermeen Usman, Urooj Mushtaq, Zunaira Mukhtar, Bisal Naseer

    Infections at hemodialysis access sites remain a critical challenge in managing end-stage renal disease patients, significantly affecting morbidity and mortality. This comprehensive review synthesizes current knowledge on risk factors, surveillance methods, diagnostic approaches, treatment strategies, and preventive measures for these infections. Through systematic analysis of literature from major databases up to July 2024, we explore infection-related complications, pathogenic agents, and management strategies. Staphylococcus aureus emerges as a primary pathogen, with concerning increases in multidrug-resistant strains. The review emphasizes the superior safety profile of arteriovenous fistulas compared to central venous catheters, highlighting the importance of access type selection. Continuous monitoring and early detection through physical examinations and specialized tests are crucial. Diagnostic accuracy is optimized by combining clinical assessment with laboratory testing and imaging studies. Treatment strategies focus on empiric systemic antibiotic therapy, guided by local epidemiology and culture results, often necessitating catheter removal for persistent infections. Preventive measures, including strict adherence to aseptic techniques and targeted use of antimicrobial locks, are detailed. The study advocates for a multifaceted approach to infection management, emphasizing multidisciplinary collaboration and adherence to evidence-based guidelines. Promising future directions, such as novel antimicrobial surfaces and lock solutions, offer potential for further reducing infection risks. This review provides valuable insights for healthcare providers, aiming to improve long-term outcomes and quality of life for hemodialysis-dependent patients through enhanced infection control strategies.


  • Open Access

    Efficacy and Safety of Colchicine in Reducing Reperfusion Injury Among Patients With ST-Segment Elevation Myocardial Infarction (STEMI): A Systematic Review and Clinical Appraisal

    by Archana Dhami, Bassel Abdul Latif el Ejel, Mazhar Khalil, Sami Ul Haq, Mansi Yadav, Asma Iqbal, Syed Ali Ahsan, Helen O. Uzokwe, Michelle C. Uzokwe, Syed Faqeer Hussain Bokhari, et al.

    This systematic review evaluated the efficacy and safety of colchicine in reducing ischemia-reperfusion injury among patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention. A comprehensive literature search across five databases identified 92 records, with five studies meeting the inclusion criteria, encompassing 390 patients. The included studies comprised randomized controlled trials and prospective studies investigating various colchicine dosing regimens, from short-term high-dose protocols to prolonged maintenance therapy. Primary outcomes included infarct size, inflammatory biomarkers, major adverse cardiovascular events, and safety profiles. Results demonstrated heterogeneous findings across studies. While one trial showed trends toward reduced inflammatory markers such as NLRP3 inflammasome activity, others failed to demonstrate significant reductions in reperfusion injury events or infarct size. Notably, the COVERT-MI trial revealed an unexpected threefold increase in left ventricular thrombus formation with colchicine therapy, raising safety concerns. Gastrointestinal side effects were also consistently reported across studies. The evidence suggests that the anti-inflammatory properties of colchicine may not translate into clinically meaningful cardioprotection in the acute phase of STEMI. Current data do not support routine colchicine administration for reperfusion injury reduction in STEMI patients undergoing primary percutaneous coronary intervention, highlighting the need for larger, well-designed trials with standardized protocols and longer follow-up periods to definitively establish its role in acute myocardial infarction management.


  • Open Access

    Role of advanced imaging in primary hepatic neuroendocrine tumor with borderline raised AFP and negative chromogranin staining: A case report

    by Asma Fatima, Suresh Chandra, Saubia Fatima, Mohammed Yasir Izhar, Syed Faqeer Hussain Bokhari, Asma Iqbal

    Background: Primary hepatic neuroendocrine tumors (PHNETs) are rare, accounting for approximately 0.3 % of all neuroendocrine tumors (NETs) and are often difficult to diagnose due to their nonspecific symptoms and imaging features. Standard diagnostic and treatment protocols are lacking due to their rarity, but imaging and immunohistochemistry (IHC) remain key tools for diagnosis. Case report: A 68-year-old male presented with abdominal discomfort and loss of appetite. Imaging revealed a large exophytic mass in the left lobe of the liver. After ruling out extrahepatic primary sources, a left lobe hepatectomy was performed. Histopathology confirmed the diagnosis of PHNET, with positive IHC staining for synaptophysin and CK-7. Postoperative PET-CT ruled out any distant metastases. The patient had an uneventful recovery. Discussion: PHNETs are believed to originate from ectopic neuroendocrine cells in the liver, though several theories exist. Imaging alone cannot conclusively diagnose PHNETs, as they mimic other hepatic tumors like hepatocellular carcinoma. Histopathological examination, along with IHC markers like chromogranin and synaptophysin, is essential for diagnosis. Surgical resection remains the treatment of choice, with good outcomes despite the risk of recurrence. Non-surgical therapies, such as chemotherapy or ablation, are under investigation but lack consensus. Conclusion: PHNETs are rare and challenging to diagnose, requiring imaging and IHC for confirmation. Surgery offers the best prognosis, making personalized, surgery-centered treatment plans essential for management. Comprehensive follow-up, including functional imaging, is necessary to monitor recurrence or metastasis. Highlights:


  • Open Access

    Efficacy of Aerobic and Stretching Exercises in Managing Willis-Ekbom Disease (Restless Leg Syndrome) Among Hemodialysis Patients

    by Mohamedalamin Alnoor Altayb Ismail, Islam Daffalla, Taranpreet Singh, Qandeel Rida Siddique, Mohammed Khaleel I. Kh. Almadhoun, Rabail Irfan, Moeez Saqib, Muhammad Haris, Zaid Khan, Jaqueline Giselle Farias Fernandes, et al.

    Restless leg syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move the legs, particularly during rest. It significantly affects the quality of life of hemodialysis patients with high prevalence in this population. While pharmacological treatments, especially dopamine agonists (DAs), are commonly used, they often come with side effects and augmentation phenomena. This systematic review examines the effectiveness of exercise interventions in managing RLS among hemodialysis patients. Eight studies, including randomized controlled trials and quasi-experimental studies, were analyzed. The interventions primarily consisted of aerobic exercises (cycling) and stretching exercises, with durations ranging from eight weeks to six months. The primary outcome measure was RLS severity, assessed using validated scales such as the International Restless Legs Syndrome Study Group (IRLSSG) scale or the Restless Legs Syndrome Questionnaire (RLSQ). Secondary outcomes included sleep quality, depression, and physical performance. The results consistently demonstrated that both aerobic and stretching exercises significantly reduced RLS severity and improved related outcomes. The intradialytic nature of some interventions offered a practical approach to incorporating exercise into patient routines. While exercise showed comparable efficacy to DAs in reducing RLS symptoms and improving depression scores, only DAs significantly enhanced sleep quality in one comparative study. These findings suggest that exercise interventions may be a viable non-pharmacological approach to managing RLS in hemodialysis patients, potentially complementing or reducing reliance on pharmacological treatments.


  • Open Access

    Spindle cell carcinoma of larynx: A case report

    by Syed Anwar Ahmad, Asma Iqbal, Syed Faqeer Hussain Bokhari, Fatima Sial

    Introduction and importance: Laryngeal Spindle Cell Carcinoma (SpCC), a rare subtype constituting only 0.5% of cases, poses diagnostic challenges due to its biphasic nature and histological resemblance to other neoplasms. Our study explores unique observations, including monoclonal epithelial origin and an unusually large tumor triggering respiratory distress. Case report: In this comprehensive case report, a 62-year-old male with a history of tuberculosis and extensive smoking presented with respiratory distress and a white vocal cord mass, diagnosed as spindle cell carcinoma (SpCC). Laryngoscopic and imaging evaluations revealed an ill-defined mass originating from the right supraglottic larynx. Histopathological examination and immunohistochemistry confirmed confirming the diagnosis. The management included immediate tracheostomy, surgical resection, adjuvant radiation therapy, and chemotherapy. Regular follow-ups and a multidisciplinary approach contributed to a successful three-year outcome without recurrence. Clinical discussion: Spindle Cell Carcinomas (SpCCs) of the larynx, historically termed carcinosarcoma and sarcomatoid carcinoma, are rare and predominantly affect middle-aged to elderly males. These biphasic tumors arise from both epithelial and spindle cell elements and present with symptoms like hoarseness and dysphagia. Risk factors include tobacco use, alcohol, and viral infections. Accurate diagnosis relies on histological and immunohistochemical analysis. Early detection facilitates favorable outcomes, with five-year survival rates ranging from 65 to 95%. Conclusion: Spindle Cell Carcinoma (SpCC) of the larynx, originating from epithelial and spindle cell elements, requires early detection through histological and immunohistochemical analysis. Early diagnosis leads to a notably optimistic five-year survival prognosis. Highlights:

  • Open Access

    Maxillofacial challenge: Rare presentation of central giant cell tumor involving both maxilla and mandible

    by Asma Iqbal, Syed Faqeer Hussain Bokhari, Muhammad Tausif

    Introduction and importance: Central giant cell tumor (CGCT) of bone is an uncommon yet locally aggressive neoplasm originating from undifferentiated mesenchymal cells in bone marrow. This case report explores a rare presentation in the maxilla extending to the mandible, emphasizing the complexity of CGCT management and the need for a multidisciplinary approach. Case presentation: A 35-year-old female presented with a progressively enlarging non-tender, firm swelling on the left maxilla and a similar mandibular swelling. Paraesthesia of the left lower lip and chin accompanied the mandibular swelling. CT scans and 3D reconstructions revealed expansive osteolytic defects affecting the maxilla and mandible. Biochemical tests supported a central giant cell tumor diagnosis. Histopathology confirmed spindle cell proliferation and multinucleated giant cells in both lesions. Surgical intervention involved excision and reconstruction. A five-month follow-up showed no recurrence, affirming the treatment's success. Clinical discussion: Central giant cell tumors (CGCTs) of bone are primarily benign, arising from undifferentiated mesenchymal cells. While mostly benign, they carry a rare potential for malignancy. Diagnosis involves imaging (CT, MRI, bone scintigraphy) and confirmation through biopsy. Surgical resection is the standard treatment, with radiotherapy considered in challenging cases. Recurrence rates vary with the extent of surgical intervention. Alternative treatments like cryotherapy and chemotherapy show varying success. Conclusion: This case emphasizes the necessity of precise histopathological diagnosis for CGCT management. The intricate nature of maxillary involvement, coupled with mandibular association, mandates a multidisciplinary approach. Surgery, while the primary treatment, should be judiciously determined based on tumor characteristics and recurrence. Highlights:


  • Open Access

    Pediatric intranasal lobular capillary hemangioma: A case report

    by Asma Iqbal, Syed Faqeer Hussain Bokhari, Syed Anwar Ahmad

    Lobular capillary hemangioma (LCH) is a benign vascular lesion typically affecting the head and neck region, especially the nasal cavity. However, its occurrence in the nasal cavity of the pediatric population is rare, making its diagnosis and management crucial in such cases. A 7-year-old female presented with left-sided nasal obstruction and recurrent epistaxis for 4 months. Examination revealed a dark purplish-red nasal mass, which bled easily upon probing. CT scans showed a soft tissue lesion with post-contrast enhancement. Histopathological examination confirmed lobular capillary hemangioma. The patient successfully underwent surgical excision without pre-operative embolization. LCH affects both the skin and mucous membranes. Although its exact etiology remains debated, trauma is a leading risk factor for its development. Biopsy and radiological investigations confirm its diagnosis. Differentiating LCH from other vascular disorders with similar presentations is essential for a thorough understanding and better management. Endoscopic surgical excision combined with electrodesiccation is the treatment of choice. Intranasal LCH in children is infrequent. An accurate diagnosis is essential for a comprehensive understanding. Surgical excision with electrodesiccation is the preferred treatment, but the role of pre-operative embolization is still under discussion.